Skip to main content

Profile hero

Profile details

About Dr. Alexander Klausmann

Alexander is a corporate associate in our global transactions team.

He advises on M&A and capital market transactions, compliance and investigations, corporate governance and corporate finance as well as on other matters of corporate and capital markets law.

Alexander speaks German and English.

Recent work

  • Advising Evotec SE on a capital increase from authorised capital and the entry of Mubadala Investment Company as a strategic investor.
  • Advising BioNTech SE on several capital measures, the placement of shares and American Depositary Shares, and the issuance of a convertible bond.
  • Advising the buyer on the acquisition of the Frankfurt hotel and office complex "THE SQUAIRE", one of the largest commercial properties in Germany.
  • Advising Lloyd Fonds AG on the acquisition of SPSW Capital GmbH and related capital measures.
  • Advising a globally acting food manufacturer on the design and implementation of its compliance management system.
  • Advising Freudenberg SE on the sale of its IT business "Freudenberg IT" (FIT) to Canadian IT company Syntax Systems Ltd., a portfolio company of Canadian financial investor Novacap.
  • Advising Hamburg Süd group on the sale of its dry bulk shipping business to The China Navigation Company, a subsidiary of the Swire group.
  • Advising Hamburg Commercial Bank AG (formerly HSH Nordbank AG) on the sale of a portfolio of non-performing loans in connection with its privatisation.
  • Advising Continental AG on the acquisition of an indirect participation in Dutch technology company HERE International B.V.
  • Advising Maersk Line A/S, the world's largest container shipping line, on its takeover of the Hamburg Süd group.

Qualifications

  • University of Freiburg, Germany (First State Exam, Dr. iur.)
  • University of Glasgow, UK (Law)
  • Hanseatic Higher Regional Court, Hamburg, Germany (Legal Training)
  • Rechtsanwalt (Attorney at Law), Germany

Publications

  • EWS 2016, 253-272 (together with Prof. Dr. Hanno Merkt, LL.M.) Die europäische und internationale Corporate Governance-Diskussion im Spiegel der ECGI-Research Paper aus der Zeit von Januar 2012 bis März 2016

  • Duncker & Humblot, Berlin 2016, 457 pages Entsendungsrechte in der Aktiengesellschaft

  • NZG 2015, 1300-1306 Gesellschaftsrechtlich zulässige Regelungen im Insolvenzplan im Sinne von § 225 a III InsO